{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nTCF3, whose primary protein products are the E‐proteins E12 and E47, functions as a master basic helix–loop–helix transcription factor that governs normal lymphocyte development. In B cells, TCF3 promotes proper immunoglobulin gene rearrangement, class switch recombination, and the generation of memory B cells, while its expression and activity also affect the maintenance of humoral immunity—even as these functions decline with age or when mutations occur that impair its DNA‐binding capacity. TCF3 regulates key downstream targets (including activation‐induced cytidine deaminase and CIITA) via cooperative interactions with chromatin co‐activators such as p300/CBP, and its alternative splicing into distinct isoforms (E12 versus E47) further fine‐tunes immune cell fate decisions and stem cell pluripotency."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "8"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nAberrant rearrangements of TCF3 are pivotal in leukemogenesis. Chromosomal translocations that fuse TCF3 with other transcription factor–encoding genes—such as the TCF3–HLF and TCF3–PBX1 fusions—drive acute lymphoblastic leukemia by reprogramming the transcriptome of lymphoid progenitors, endowing these cells with stem cell–like and drug‐resistant features. These fusion proteins perturb normal TCF3 target gene regulation, collaborate with other hematopoietic regulators, and are associated with poor clinical outcome, thus representing both a mechanistic insight into leukemic transformation and potential targets for therapeutic intervention."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "9", "end_ref": "16"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond its roles in the immune system, TCF3 orchestrates diverse differentiation programs in other tissues. In solid tumors such as breast cancer and rhabdomyosarcoma, for example, TCF3 modulates the expression of microRNAs and E‐cadherin to influence cell invasion and the epithelial–mesenchymal transition, respectively, often in interplay with inhibitors (Id proteins) or kinases that alter its phosphorylation state. TCF3 also cooperates with SMAD factors during mesendoderm specification and with tissue‐specific factors in pancreatic β cells to enhance insulin gene expression. These actions—mediated through direct promoter binding, recruitment of coactivators, and regulated by alternative splicing—underscore the broader impact of TCF3 on cellular fate, proliferation, and differentiation."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "17", "end_ref": "27"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Daniela Frasca, Ana Marie Landin, Suzanne C Lechner, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Aging down-regulates the transcription factor E2A, activation-induced cytidine deaminase, and Ig class switch in human B cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Immunol (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.4049/jimmunol.180.8.5283"}], "href": "https://doi.org/10.4049/jimmunol.180.8.5283"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18390709"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18390709"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Bertrand Boisson, Yong-Dong Wang, Amma Bosompem, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A recurrent dominant negative E47 mutation causes agammaglobulinemia and BCR(-) B cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Invest (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1172/JCI71927"}], "href": "https://doi.org/10.1172/JCI71927"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24216514"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24216514"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Curtis Bradney, Mark Hjelmeland, Yasuhiko Komatsu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Regulation of E2A activities by histone acetyltransferases in B lymphocyte development."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M211464200"}], "href": "https://doi.org/10.1074/jbc.M211464200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12435739"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12435739"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Nienke van der Stoep, Edwin Quinten, Marisa Marcondes Rezende, et al. "}, {"type": "b", "children": [{"type": "t", "text": "E47, IRF-4, and PU.1 synergize to induce B-cell-specific activation of the class II transactivator promoter III (CIITA-PIII)."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Blood (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1182/blood-2004-03-0790"}], "href": "https://doi.org/10.1182/blood-2004-03-0790"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15242870"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15242870"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Ruth Schwartz, Isaac Engel, Mohammad Fallahi-Sichani, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Gene expression patterns define novel roles for E47 in cell cycle progression, cytokine-mediated signaling, and T lineage development."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.0603728103"}], "href": "https://doi.org/10.1073/pnas.0603728103"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16782810"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16782810"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Takashi Yamazaki, Lizhi Liu, Denis Lazarev, et al. "}, {"type": "b", "children": [{"type": "t", "text": "TCF3 alternative splicing controlled by hnRNP H/F regulates E-cadherin expression and hESC pluripotency."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Genes Dev (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1101/gad.316984.118"}], "href": "https://doi.org/10.1101/gad.316984.118"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30115631"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30115631"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Daniela Frasca, Alain Diaz, Maria Romero, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNAs miR-155 and miR-16 Decrease AID and E47 in B Cells from Elderly Individuals."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Immunol (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.4049/jimmunol.1500520"}], "href": "https://doi.org/10.4049/jimmunol.1500520"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26223652"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26223652"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Ramiro Gisler, Mikael Sigvardsson "}, {"type": "b", "children": [{"type": "t", "text": "The human V-preB promoter is a target for coordinated activation by early B cell factor and E47."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Immunol (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.4049/jimmunol.168.10.5130"}], "href": "https://doi.org/10.4049/jimmunol.168.10.5130"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "11994467"}], "href": "https://pubmed.ncbi.nlm.nih.gov/11994467"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Ute Fischer, Michael Forster, Anna Rinaldi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Genomics and drug profiling of fatal TCF3-HLF-positive acute lymphoblastic leukemia identifies recurrent mutation patterns and therapeutic options."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Genet (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ng.3362"}], "href": "https://doi.org/10.1038/ng.3362"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26214592"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26214592"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "T Inukai, K Hirose, T Inaba, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Hypercalcemia in childhood acute lymphoblastic leukemia: frequent implication of parathyroid hormone-related peptide and E2A-HLF from translocation 17;19."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Leukemia (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/sj.leu.2404496"}], "href": "https://doi.org/10.1038/sj.leu.2404496"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17183364"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17183364"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Kerry E Barber, Christine J Harrison, Zoe J Broadfield, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Molecular cytogenetic characterization of TCF3 (E2A)/19p13.3 rearrangements in B-cell precursor acute lymphoblastic leukemia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Genes Chromosomes Cancer (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/gcc.20431"}], "href": "https://doi.org/10.1002/gcc.20431"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17311319"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17311319"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Giovanna Casagrande, Geertruy te Kronnie, Giuseppe Basso "}, {"type": "b", "children": [{"type": "t", "text": "The effects of siRNA-mediated inhibition of E2A-PBX1 on EB-1 and Wnt16b expression in the 697 pre-B leukemia cell line."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Haematologica (2006)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16769578"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16769578"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "S Jiménez-Morales, E Miranda-Peralta, Y Saldaña-Alvarez, et al. "}, {"type": "b", "children": [{"type": "t", "text": "BCR-ABL, ETV6-RUNX1 and E2A-PBX1: prevalence of the most common acute lymphoblastic leukemia fusion genes in Mexican patients."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Leuk Res (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.leukres.2008.03.021"}], "href": "https://doi.org/10.1016/j.leukres.2008.03.021"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18455790"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18455790"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Kinuko Hirose, Takeshi Inukai, Jiro Kikuchi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Aberrant induction of LMO2 by the E2A-HLF chimeric transcription factor and its implication in leukemogenesis of B-precursor ALL with t(17;19)."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Blood (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1182/blood-2009-09-244673"}], "href": "https://doi.org/10.1182/blood-2009-09-244673"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20519628"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20519628"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Wen-Chieh Pi, Jun Wang, Miho Shimada, et al. "}, {"type": "b", "children": [{"type": "t", "text": "E2A-PBX1 functions as a coactivator for RUNX1 in acute lymphoblastic leukemia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Blood (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1182/blood.2019003312"}], "href": "https://doi.org/10.1182/blood.2019003312"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32276273"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32276273"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Jinhua Piao, Shiori Takai, Takahiro Kamiya, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Poly (ADP-ribose) polymerase inhibitors selectively induce cytotoxicity in TCF3-HLF-positive leukemic cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Lett (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.canlet.2016.11.021"}], "href": "https://doi.org/10.1016/j.canlet.2016.11.021"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27894958"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27894958"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "W W Hwang-Verslues, P-H Chang, P-C Wei, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-495 is upregulated by E12/E47 in breast cancer stem cells, and promotes oncogenesis and hypoxia resistance via downregulation of E-cadherin and REDD1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/onc.2010.618"}], "href": "https://doi.org/10.1038/onc.2010.618"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21258409"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21258409"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Zhihong Yang, Kyle L MacQuarrie, Erwin Analau, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MyoD and E-protein heterodimers switch rhabdomyosarcoma cells from an arrested myoblast phase to a differentiated state."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Genes Dev (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1101/gad.1765109"}], "href": "https://doi.org/10.1101/gad.1765109"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19299559"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19299559"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Eva Cubillo, Antonio Diaz-Lopez, Eva P Cuevas, et al. "}, {"type": "b", "children": [{"type": "t", "text": "E47 and Id1 interplay in epithelial-mesenchymal transition."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0059948"}], "href": "https://doi.org/10.1371/journal.pone.0059948"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23555842"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23555842"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Se-Jin Yoon, Andrea E Wills, Edward Chuong, et al. "}, {"type": "b", "children": [{"type": "t", "text": "HEB and E2A function as SMAD/FOXH1 cofactors."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Genes Dev (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1101/gad.16800511"}], "href": "https://doi.org/10.1101/gad.16800511"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21828274"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21828274"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Richard Bayly, Luan Chuen, Richard A Currie, et al. "}, {"type": "b", "children": [{"type": "t", "text": "E2A-PBX1 interacts directly with the KIX domain of CBP/p300 in the induction of proliferation in primary hematopoietic cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M408654200"}], "href": "https://doi.org/10.1074/jbc.M408654200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15507449"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15507449"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Craig Slattery, Tara McMorrow, Michael P Ryan "}, {"type": "b", "children": [{"type": "t", "text": "Overexpression of E2A proteins induces epithelial-mesenchymal transition in human renal proximal tubular epithelial cells suggesting a potential role in renal fibrosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "FEBS Lett (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.febslet.2006.06.039"}], "href": "https://doi.org/10.1016/j.febslet.2006.06.039"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16814783"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16814783"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Jody M Lingbeck, Julie S Trausch-Azar, Aaron Ciechanover, et al. "}, {"type": "b", "children": [{"type": "t", "text": "E12 and E47 modulate cellular localization and proteasome-mediated degradation of MyoD and Id1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/sj.onc.1208789"}], "href": "https://doi.org/10.1038/sj.onc.1208789"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16007194"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16007194"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "G Zhu, X Li, B Guo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "PAK5-mediated E47 phosphorylation promotes epithelial-mesenchymal transition and metastasis of colon cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/onc.2015.259"}], "href": "https://doi.org/10.1038/onc.2015.259"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26212009"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26212009"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Han-Jong Kim, Joon-Young Kim, Yun-Yong Park, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Synergistic activation of the human orphan nuclear receptor SHP gene promoter by basic helix-loop-helix protein E2A and orphan nuclear receptor SF-1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nucleic Acids Res (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/nar/gkg906"}], "href": "https://doi.org/10.1093/nar/gkg906"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "14627819"}], "href": "https://pubmed.ncbi.nlm.nih.gov/14627819"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Michiyo Amemiya-Kudo, Junko Oka, Tomohiro Ide, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Sterol regulatory element-binding proteins activate insulin gene promoter directly and indirectly through synergy with BETA2/E47."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M506718200"}], "href": "https://doi.org/10.1074/jbc.M506718200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16055439"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16055439"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Pankaj Sharma, Swathi Chinaranagari, Jaideep Chaudhary "}, {"type": "b", "children": [{"type": "t", "text": "Inhibitor of differentiation 4 (ID4) acts as an inhibitor of ID-1, -2 and -3 and promotes basic helix loop helix (bHLH) E47 DNA binding and transcriptional activity."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochimie (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.biochi.2015.03.006"}], "href": "https://doi.org/10.1016/j.biochi.2015.03.006"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25778840"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25778840"}]}]}]}